Published 11/02/2009 by Market Wire via MSN Money
Adeona Receives IRB Approval to Initiate Clinical Trial of
Adeona Pharmaceuticals, Inc. (AMEX: AEN), a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the mature population, today announced that it has received Institutional Review Board (IRB) approval...
Share this
What others report on the same story